November 12, 2013
AdhereTech's smart pill bottle.
The market for digital tools that improve medication adherence is heating up. Over the last year Mango Health launched, AdhereTech announced a new clinical trial, Janssen Healthcare Innovations completely revamped its Care4Today app, and Proteus demonstrated its tracking accuracy. And we're constantly learning about new devices and apps like those from...
January 18, 2013
Care4Today by Janssen Healthcare Innovation
For one reason or another, as many as half the patients in the United States don't take the medication that is prescribed to them at a cost to the US healthcare system of $290 billion a year in waste. That's according to NEHI, formerly known as the New England Healthcare Institute, which has been tracking the medication adherence problem for years....
August 15, 2009
A new report conducted by the New England Healthcare Institute (NEHI) found that not taking medications as prescribed leads to poorer health, more frequent hospitalization, a higher risk of death and as much as $290 billion annually in increased medical costs. Anywhere from one-third to one-half of patients in the U.S. do not take their medications as instructed. Not taking the medication on time...
August 14, 2009
Cambridge, Massachusetts-based Vitality announced the commercial availability of its wireless Internet-enabled pill caps product, GlowCaps, which fit popular prescription bottles and help remind people to take their medications on time. GlowCaps are now available on Amazon.com for $99.
As the name suggests, GlowCaps use light and sound to signal when it is time to take medications, the product...
June 11, 2009
Proteus Biomedical CEO Andrew Thompson describes his company as a pioneer of intelligent medicine -- Proteus embeds computers and sensors inside drugs and devices to monitor in real-time when a patient takes a drug and how they respond to it. Thompson says the service will also include reminders and notices for patients' caregivers or family members to keep them in the loop. And although Thomspon...